NSE/LASA

LASALASA

NSE Equity · NSE

₹8.48+4.95%

52-wk low52-WEEK RANGE52-wk high

₹5.67+49.6% from low ·-54.1% from high₹18.47

Price chart · 1M–10Y · daily-close

NSE bhavcopy + 10Y historical

LASA-94.24% · 1Y

Range high ₹214Range low ₹5.67Latest ₹8.48Powered by TradingView · live NSE data

NSE EquityDrug Manufacturers - Specialty & GenericMicrocapLow Risk

Stock scorecard

Auto-computed from latest ratios + sector context · not a buy/sell signal

Composite50/100

Performance

Low

Hasn't fared well — amongst the weak performers.

· 52w return -52.2% — underperformer
· Below 200-DMA (-11.1%) — downtrend

Valuation

Low

Appears to be fairly valued to cheap vs peers.

· P/E 2.3 vs sector median 24.8 — 91% cheaper
· P/B 0.77 below sector median 2.26

Growth

Low

Lagging the market in growth.

· Revenue YoY -93.3% — contracting

Profitability

High

Showing good signs of profitability & efficiency.

· ROE 32.9% — high-quality compounder
· Top quartile ROE in Other

DVM composite · Durability · Valuation · Momentum

Trendlyne-style 3-axis composite · all drivers shown below · not a buy/sell signal

CompositeA(78/100)

Durability

A+

100/100

Financially resilient — strong quality + solvency profile.

Show 2 drivers

Debt/Equity0.13 (100pt)
ROE32.9% (100pt)

Valuation

A+

94/100

Attractively valued vs peers and growth — good margin of safety.

Show 3 drivers

P/E vs sector (2.3 / 24.8)9% (100pt)
P/B0.77 (100pt)
EV/EBITDA8.8 (70pt)

Momentum

40/100

Momentum is muted; trend is unclear or rolling over.

Show 5 drivers

52w change-52.2% (0pt)
DMA-trend alignmentsideways (50pt)
RSI (14)68.1 (87pt)
Price vs 200-DMA-13.4% (33pt)
MACD regimebullish (75pt)

Valuation positioning

Current ratio vs sector peer distribution

P/E (TTM)2.34

UNDERVALUED

CheapestP/E 2.3 at 1th %ile of sector — cheaper than 99% of peers.Most expensive

P/B0.77

UNDERVALUED

CheapestP/B 0.77 at 13th %ile of sector.Most expensive

EV/EBITDA8.82

FAIR

Monthly seasonality

Avg monthly return over 9 years · historical — not a forecast

Best: Apr +23.16% · Worst: Mar -19.66%

Jan

+3.6%

44% win

Feb

-10.7%

11% win

Mar

-19.7%

11% win

Apr

+23.2%

89% win

May

-14.3%

0% win

Jun

-12.2%

Monthly return distribution

Distribution of 103 monthly returns

Mean

-0.25%

Median

-1.28%

Std dev

22.28%

Best

+78.2%

Worst

-40.5%

% positive

44%

SWOT analysis

Auto-derived from ratios + sector context + forensics · research only, not a recommendation

STRENGTHS · 3

High-quality compounder (ROE 32.9%)
Above 20% ROE consistently flags capital-efficient businesses
Lean balance sheet (D/E 0.13)
Low leverage means earnings are less sensitive to rate cycles
Top quartile ROE in Other
Rank 39 of 1000 peers

WEAKNESSES · 1

Revenue contracting (-93.3% YoY)
Negative top-line growth is the hardest signal to overcome

OPPORTUNITIES · 0

No strong near-term catalysts visible

THREATS · 0

No immediate threats from the data

RETURNS · DAILY-CLOSE BASED

3Y+ shown as CAGR

+5.0%

+11.3%

+16.3%

-26.1%

-28.0%

-52.1%

-26.4%

-33.3%

10Y

-28.3%

Peer	Last close	1Y change	Mcap ₹Cr	P/E	P/B	ROE	D/E	Rev YoY
LASATHIS Lasa Supergenerics Limited	₹8.48	-52.2%	43	2.3	0.77	32.9%	0.13	-93.3%
ABCAPITAL Aditya Birla Capital Limited	₹340.4	+68.1%	89,888	25.8	2.79	10.8%	4.60	+17.6%
ABBOTINDIA Abbott India Limited	₹25,785	-16.6%	54,547	35.8	13.60	38.0%	0.04	+9.6%
360ONE 360 ONE WAM LIMITED	₹1,113.3	+16.7%	44,744	38.7	4.77	12.3%	1.47	+35.0%
3MINDIA 3M India Limited	₹31,410	+4.4%	35,158	92.9	21.83	23.5%	0.06	+6.1%
AADHARHFC Aadhar Housing Finance Limited	₹496.45	+3.5%	21,173	20.8	3.05	14.6%	2.55	—
ABDL Allied Blenders and Distillers Limited	₹573.8	+76.4%	16,176	60.4	10.70	17.7%	0.67	+5.8%
AAVAS Aavas Financiers Limited	₹1,347.9	-37.8%	10,612	17.1	2.26	13.3%	3.08	+13.3%
63MOONS 63 moons technologies limited	₹662.7	-9.8%	8,006	—	0.92	-0.2%	0.00	-6.3%

ASK AXEL

Dig deeper into LASA

Axel can fetch latest news, peer valuation, consensus estimates, insider activity, and concall commentary for LASA — all in one sourced reply.

Ask free in chat

Run these tools on LASA

Historical return →

"If I had bought LASA in year X"

Rolling returns →

Worst/best 1/3/5/7/10-yr windows

Buy-the-dip backtester →

Dip-buying vs SIP on LASA

Brokerage + charges →

All-in cost for trading LASA

Research tool · not investment advice.

Axel Markets is an information + analytics product. We are not a SEBI-registered Research Analyst (RA) or Investment Adviser (IA). Nothing on this page is a buy, sell, or hold recommendation. Past performance is not indicative of future returns. Verify all data against the authoritative source (NSE, BSE, AMFI, SEBI, company RHP / factsheet) before acting. Daily OHLCV sourced primarily from our NSE bhavcopy ingest (public sec_bhavdata_full CSV), with Stooq as a fallback for historical gaps. Split + bonus adjusted. Excludes dividends. Not a recommendation. Past performance does not predict future returns. For authoritative live quotes see NSE / BSE directly.

Date	Amount
2022-09-16	₹0.25
2021-09-15	₹0.25

LASALASA

Price chart · 1M–10Y · daily-close

Stock scorecard

DVM composite · Durability · Valuation · Momentum

Valuation positioning

Monthly seasonality

Monthly return distribution

SWOT analysis

Fundamentals

Pros and cons

Sector-relative context

Company + balance sheet snapshot

Peer comparison · Other

Ask Axel about LASA

Recent news

Dig deeper into LASA

Run these tools on LASA

Technical snapshot

Dividends + splits history

DVM composite · Durability · Valuation · Momentum

Valuation positioning

Monthly seasonality

Monthly return distribution

SWOT analysis

Recent news

Stock scorecard

Fundamentals

Pros and cons

Sector-relative context

Company + balance sheet snapshot

Peer comparison · Other